1. Cancers (Basel). 2019 Oct 9;11(10):1518. doi: 10.3390/cancers11101518.

A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth.

Lospinoso Severini L(1), Quaglio D(2), Basili I(3), Ghirga F(4), Bufalieri F(5), 
Caimano M(6), Balducci S(7), Moretti M(8), Romeo I(9), Loricchio E(10), Maroder 
M(11), Botta B(12), Mori M(13), Infante P(14), Di Marcotullio L(15)(16).

Author information:
(1)Department of Molecular Medicine, Sapienza University, Viale Regina Elena 
291, 00161 Rome, Italy. ludovica.lospinososeverini@uniroma1.it.
(2)Department of Chemistry and Technology of Drugs, Sapienza University, 
Piazzale A. Moro 5, 00161 Rome, Italy. deborah.quaglio@uniroma1.it.
(3)Department of Molecular Medicine, Sapienza University, Viale Regina Elena 
291, 00161 Rome, Italy. irenebasili.ib@gmail.com.
(4)CLNS@Sapienza, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 
Rome, Italy. francesca.ghirga@iit.it.
(5)Department of Molecular Medicine, Sapienza University, Viale Regina Elena 
291, 00161 Rome, Italy. francesca.bufalieri@uniroma1.it.
(6)Department of Molecular Medicine, Sapienza University, Viale Regina Elena 
291, 00161 Rome, Italy. miriam.caimano@uniroma1.it.
(7)Department of Chemistry and Technology of Drugs, Sapienza University, 
Piazzale A. Moro 5, 00161 Rome, Italy. silvia.balducci@uniroma1.it.
(8)Department of Experimental Medicine, Sapienza University, Viale Regina Elena 
324, 00161 Rome, Italy. marta.moretti@uniroma1.it.
(9)Department of Chemistry and Technology of Drugs, Sapienza University, 
Piazzale A. Moro 5, 00161 Rome, Italy. isabella.romeo1988@gmail.com.
(10)Department of Molecular Medicine, Sapienza University, Viale Regina Elena 
291, 00161 Rome, Italy. elena.loricchio@uniroma1.it.
(11)Department of Molecular Medicine, Sapienza University, Viale Regina Elena 
291, 00161 Rome, Italy. marella.maroder@uniroma1.it.
(12)Department of Chemistry and Technology of Drugs, Sapienza University, 
Piazzale A. Moro 5, 00161 Rome, Italy. bruno.botta@uniroma1.it.
(13)Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 
via Aldo Moro 2, 53100 Siena, Italy. mattia.mori@unisi.it.
(14)CLNS@Sapienza, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 
00161 Rome, Italy. paola.infante@iit.it.
(15)Department of Molecular Medicine, Sapienza University, Viale Regina Elena 
291, 00161 Rome, Italy. lucia.dimarcotullio@uniroma1.it.
(16)Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci 
Bolognetti-Department of Molecular Medicine, Sapienza University, Viale Regina 
Elena 291, 00161 Rome, Italy. lucia.dimarcotullio@uniroma1.it.

: Pharmacological Hedgehog (Hh) pathway inhibition has emerged as a valuable 
anticancer strategy. A number of small molecules able to block the pathway at 
the upstream receptor Smoothened (Smo) or the downstream effector 
glioma-associated oncogene 1 (Gli1) has been designed and developed. In a recent 
study, we exploited the high versatility of the natural isoflavone scaffold for 
targeting the Hh signaling pathway at multiple levels showing that the 
simultaneous targeting of Smo and Gli1 provided synergistic Hh pathway 
inhibition stronger than single administration. This approach seems to 
effectively overcome the drug resistance, particularly at the level of Smo. 
Here, we combined the pharmacophores targeting Smo and Gli1 into a single and 
individual isoflavone, compound 22, which inhibits the Hh pathway at both 
upstream and downstream level. We demonstrate that this multitarget agent 
suppresses medulloblastoma growth in vitro and in vivo through antagonism of Smo 
and Gli1, which is a novel mechanism of action in Hh inhibition.

DOI: 10.3390/cancers11101518
PMCID: PMC6826940
PMID: 31601026

Conflict of interest statement: The authors declare no conflict of interest.